| Scrip code | 544286 |
|---|---|
| NSE Symbol | NIVABUPA |
| MSEI Symbol | NOTLISTED |
| ISIN | INE995S01015 |
| Name of Company | NIVA BUPA HEALTH INSURANCE COMPANY LIMITED |
| Type of company | Main Board |
| Class of security | Equity |
| Type Of Insurance | Non-Linked Policy |
| Date of start of financial year | 01-04-2025 |
| Date of end of financial year | 31-03-2026 |
| Date of board meeting when results were approved | 03-11-2025 |
| Date on which prior intimation of the meeting for considering financial results was informed to the exchange | 28-10-2025 |
| Description of presentation currency | INR |
| Level of rounding used in financial results | Lakhs |
| Reporting Type | Quarterly |
| Reporting Quarter | Second quarter |
| Nature of report standalone or consolidated | Standalone |
| Whether results are audited or unaudited for the quarter ended | Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended | Unaudited |
| Start date and time of board meeting | 03-11-2025 16:00:00 |
| End date and time of board meeting | 03-11-2025 17:00:00 |
| Whether cash flow statement is applicable on company | Yes |
| Type of cash flow statement | Cash Flow Direct |
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Whether the company has any related party? | Yes |
| Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? | No |
| (I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public | NA |
| (II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. | NA |
| (III) Whether the company is a high value debt listed entity according to regulation 15(1A)? | No |
| (a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication? | |
| (b) If answer to above question is No, please explain the reason for not complying. | |
| Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? | Yes |
| Latest Date on which RPT policy is updated | 31-07-2025 |
| Indicate Company website link for updated RPT policy of the Company | https://transactions.nivabupa.com/pages/doc/investor-relations/policies/Related_Party_Transaction_Policy.pdf |
| Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? | Yes |
| No. of times funds raised during the quarter | 1 |
| Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? | No |
| No default on loan and debt securities during the quarter ended September, 2025 | |
| Partiuclars | Current Quarter | Year to Date Figures | |
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| OPERATING RESULTS | |||
| 1 | Operating income | ||
| (i) | Gross Premiums Written | 1,84,307.00 | 3,47,497.00 |
|---|---|---|---|
| (ii) | Net Premium written | 1,45,006.00 | 2,73,793.00 |
| (iii) | Premium Earned (Net) | 1,42,205.00 | 2,64,204.00 |
| (iv) | Income from investments (net) | 9,813.00 | 18,496.00 |
| (v) | Other income | ||
| 1 | Other Income | 0.00 | 0.00 |
| 2 | Contribution from the Shareholders' Account | 0.00 | 0.00 |
| 3 | (a) Towards Excess Expenses of Management | 1,713.00 | 1,872.00 |
| 4 | (b) Towards remuneration of MD/CEO/WTD/Other KMPs | 77.00 | 77.00 |
| 5 | (c) Others | 0.00 | 0.00 |
| Total other income | 1,790.00 | 1,949.00 | |
| (vi) | Total income | 1,53,808.00 | 2,84,649.00 |
| 2 | Operating expenses | ||
| (i) | Commissions & Brokerage (net) | 27,984.00 | 53,964.00 |
| (ii) | Net commission | 27,984.00 | 53,964.00 |
| (iii) | Operating Expenses related to insurance business | ||
| (a) | Employees remuneration and welfare expenses | 16,547.00 | 33,171.00 |
| (b) | Other operating expenses | ||
| 0 | Advertisement and publicity | 6,589.00 | 8,446.00 |
| 1 | Other expenses | 7,631.00 | 13,542.00 |
| Total other operating expenses | 14,220.00 | 21,988.00 | |
| (c) | Total operating expenses related to insurance business | 30,767.00 | 55,159.00 |
| (iv) | Premium Deficiency | 0.00 | 0.00 |
| (v) | Incurred Claims | ||
| (a) | Claims Paid | 96,083.00 | 1,81,038.00 |
| (b) | Change in Outstanding Claims (incl. IBNR/IBNER) | 5,174.00 | 15,210.00 |
| Total Incurred claims | 1,01,257.00 | 1,96,248.00 | |
| (vi) | Total Expense | 1,60,008.00 | 3,05,371.00 |
| (vii) | Underwriting Profit(Loss) | (17,803.00) | (41,167.00) |
| (viii) | Provisions for doubtful debts (including bad debts written off) | 0.00 | 0.00 |
| (ix) | Provisions for diminution in value of investments | 0.00 | 0.00 |
| (x) | Operating Profit/loss: | (6,200.00) | (20,722.00) |
| (xi) | Appropriations | ||
| (a) | Transfer to Profit and Loss A/c | (6,200.00) | (20,722.00) |
| (b) | Transfer to reserves | 0.00 | 0.00 |
| NON-OPERATING RESULTS | |||
| 1 | Income in shareholder's account | ||
| (a) | Transfer from Policyholders' Fund | (6,200.00) | (20,722.00) |
| (b) | Income from investments | 5,385.00 | 11,808.00 |
| (c) | Other income | ||
| 1 | Other income | 4.00 | 5.00 |
| Total other income | 4.00 | 5.00 | |
| Total income | (811.00) | (8,909.00) | |
| 2 | Expenses | ||
| (i) | Expenses other than those related to insurance business | 2,473.00 | 3,316.00 |
| (ii) | Provisions for doubtful debts (including bad debts written off) | 243.00 | 446.00 |
| (iii) | Provisions for diminution in value of investments | 0.00 | 0.00 |
| Total Expense | 2,716.00 | 3,762.00 | |
| 3 | Profit / Loss before extraordinary items |
(3,527.00) | (12,671.00) |
| 4 | Extraordinary Items |
0.00 | 0.00 |
| 5 | Profit/ (loss) before tax |
(3,527.00) | (12,671.00) |
| 6 | Provision for tax |
0.00 | 0.00 |
| 7 | Profit / (loss) after tax |
(3,527.00) | (12,671.00) |
| 8 | Divident per share | ||
| (a) | Interim Dividend | 0.00 | 0.00 |
| (b) | Final dividend | 0.00 | 0.00 |
| 9 | Opening Balance and Appropriations from PAT (Net) | (80,989.00) | (71,845.00) |
| 10 | Profit (loss) carried to balance sheet | (84,516.00) | (84,516.00) |
| 11 | Paid up equity capital | 1,84,600.00 | 1,84,600.00 |
| 12 | Reserve and Surplus (Excluding Revaluation Reserve) | 1,10,996.00 | 1,10,996.00 |
| 13 | Fair value change account and revaluation reserve | 683.00 | 683.00 |
| 14 | Assets | ||
| (a) | Investments | ||
| (i) | Shareholders Fund | 3,37,601.00 | 3,37,601.00 |
| (ii) | Policyholders' Fund | 5,10,575.00 | 5,10,575.00 |
| Total investments | 8,48,176.00 | 8,48,176.00 | |
| (b) | Other Assets (Net of current liabilities and provisions) | (5,26,897.00) | (5,26,897.00) |
| Total assets | 3,21,279.00 | 3,21,279.00 | |
| Analytical Ratios | |||
| (i) | Solvency ratio | 285.00 | 285.00 |
| (ii) | Expenses of management ratio | 38.8900 | 38.400 |
| (iii) | Incurred Claim Ratio | 71.200 | 74.2800 |
| (iv) | Net retention ratio | 78.6800 | 78.7900 |
| (v) | Combined ratio | 111.7200 | 114.1300 |
| (vi) | Earning per share | ||
| (a) | Basic and diluated EPS before extraordinary items (net of tax expense) for the period (not to be annualized) | -0.19 | -0.69 |
| (b) | Basic and diluted EPS after extraordinary items (net of tax expense) for the period (not to be annualized) | -0.19 | -0.69 |
| (vii) | NPA ratios | ||
| (a) | Gross NPAs | 4,997.00 | 4,997.00 |
| (c) | Net NPAs | 0.00 | 0.00 |
| (b) | Percentage of Gross NPAs | 0.5900 | 0.5900 |
| (d) | Percentage of net NPAs | 0 | 0 |
| (viii) | Yield on Investments | ||
| (a) | Without unrealized gains | 1.83 | 3.64 |
| (b) | With unrealised gains | 1.02 | 3.93 |
| (ix) | Public shareholding (in case of public sector insurance companies) | ||
| (a) | Number of shares | 823308601 | 823308601 |
| (b) | Percentage of shareholding | 44.600 | 44.600 |
| (c) | Percentage of government holding | 0 | 0 |
| Investor Compliants | |||
| (i) | No of investor complaints pending at the beginning of the period | 0 | 1 |
| (ii) | No of investor complaints during the period | 0 | 0 |
| (iii) | No of investor complaints disposed off during the period | 0 | 1 |
| (iv) | No of investor complaints remaining unresolved at the end of the period | 0 | 0 |
| (c) | Notes Format for financial results by general insurance companies filed with stock exchanges |
| 1. Net Premium written is Net of reinsurance (including excess of loss reinsurance). 2. Income from Investments (Net) is Net of amortisation and losses (including capital gains). 3. Commission and Brokerage (Net) is net of commission received on reinsurance cession. 4. Reserves & Surplus (excluding revaluation reserve) is Net of debit balance in Profit & Loss Account. 5. Analytical ratios have been calculated as per definition given in IRDAI analytical ratios disclosures. 5a The Solvency has been computed at the last day of the period. 5b The Expenses of Management has been computed on the basis of Gross Direct Premium. 5c Earning per share figures for the three months ended and year to date ended are not annualised. 5d (a) % of Gross NPA = Gross NPA / Total Investments. (b) % of Net NPA = (Gross NPA - Provision on investments) / (Total Investments - Provision on investments). 5e Yield on investment is computed on average of Opening & Closing Investment. |
| Partiuclars | Current Quarter | Year to Date Figures | |
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Income | |||
| 1 | Fire | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| 2 | Marine | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| 3 | Health including personal accident | ||
| (i) | Net premium | 1,42,205.00 | 2,64,204.00 |
| (ii) | Income form investments | 9,813.00 | 18,496.00 |
| (iii) | Other income | 1,790.00 | 1,949.00 |
| 4 | Health retail | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| 5 | Health group | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| 6 | Health government schemes | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| 7 | Motor | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| 8 | Retail | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| 9 | Group and corporate | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| 10 | Any other class as may be specified by the Authority. - Enter the name below | ||
| (1) | Other segment 1 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (2) | Other segment 2 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (3) | Other segment 3 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (4) | Other segment 4 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (5) | Other segment 5 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (6) | Other segment 6 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (7) | Other segment 7 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (8) | Other segment 8 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (9) | Other segment 9 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| (10) | Other segment 10 | ||
| Name of other segment | 0 | ||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
| Unallocated | |||
| (i) | Net premium | 0.00 | 0.00 |
| (ii) | Income form investments | 0.00 | 0.00 |
| (iii) | Other income | 0.00 | 0.00 |
Notes to the Income |
| 1. Health including Personal accident includes Travel Insurance. 2. Income from Investment and Other Income which cannot be allocated to any segment are apportioned on the basis of Gross Direct Premium. |
| Partiuclars | Current Quarter | Year to Date Figures | |
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Premium Deficiency | |||
| 1 | Fire | 0.00 | 0.00 |
| 2 | Marine | 0.00 | 0.00 |
| 3 | Health including personal accident | 0.00 | 0.00 |
| 4 | Health Retail | 0.00 | 0.00 |
| 5 | Health Group | 0.00 | 0.00 |
| 6 | Health Government Schemes | 0.00 | 0.00 |
| 7 | Motor | 0.00 | 0.00 |
| 8 | Retail | 0.00 | 0.00 |
| 9 | Group And Corporate | 0.00 | 0.00 |
| 10 | Any other class as may be specified by the Authority. - Enter the name below | ||
| Name of Other Segment | |||
| 1 | 0 | 0.00 | 0.00 |
| 2 | 0 | 0.00 | 0.00 |
| 3 | 0 | 0.00 | 0.00 |
| 4 | 0 | 0.00 | 0.00 |
| 5 | 0 | 0.00 | 0.00 |
| 6 | 0 | 0.00 | 0.00 |
| 7 | 0 | 0.00 | 0.00 |
| 8 | 0 | 0.00 | 0.00 |
| 9 | 0 | 0.00 | 0.00 |
| 10 | 0 | 0.00 | 0.00 |
| 11 | Unallocated | 0.00 | 0.00 |
| Partiuclars | Current Quarter | Year to Date Figures | |
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Underwriting Profit/Loss | |||
| 1 | Fire | 0.00 | 0.00 |
| 2 | Marine | 0.00 | 0.00 |
| 3 | Health including personal accident | (17,803.00) | (41,167.00) |
| 4 | Health Retail | 0.00 | 0.00 |
| 5 | Health Group | 0.00 | 0.00 |
| 6 | Health Government Schemes | 0.00 | 0.00 |
| 7 | Motor | 0.00 | 0.00 |
| 8 | Retail | 0.00 | 0.00 |
| 9 | Group And Corporate | 0.00 | 0.00 |
| 10 | Any other class as may be specified by the Authority. - Enter the name below | ||
| Name of Other Segment | |||
| 1 | 0 | 0.00 | 0.00 |
| 2 | 0 | 0.00 | 0.00 |
| 3 | 0 | 0.00 | 0.00 |
| 4 | 0 | 0.00 | 0.00 |
| 5 | 0 | 0.00 | 0.00 |
| 6 | 0 | 0.00 | 0.00 |
| 7 | 0 | 0.00 | 0.00 |
| 8 | 0 | 0.00 | 0.00 |
| 9 | 0 | 0.00 | 0.00 |
| 10 | 0 | 0.00 | 0.00 |
| 11 | Unallocated | 0.00 | 0.00 |
Notes to the Underwriting ProfitLoss |
| 1. Health including Personal accident includes Travel Insurance. |
| Partiuclars | Current Quarter | Year to Date Figures | |
| Date of start of reporting period | 01-07-2025 | 01-04-2025 | |
| Date of end of reporting period | 30-09-2025 | 30-09-2025 | |
| Whether results are audited or unaudited | Unaudited | Unaudited | |
| Nature of report standalone or consolidated | Standalone | Standalone | |
| Segment Operating Profit/Loss | |||
| 1 | Fire | 0.00 | 0.00 |
| 2 | Marine | 0.00 | 0.00 |
| 3 | Health including personal accident | (6,200.00) | (20,722.00) |
| 4 | Health Retail | 0.00 | 0.00 |
| 5 | Health Group | 0.00 | 0.00 |
| 6 | Health Government Schemes | 0.00 | 0.00 |
| 7 | Motor | 0.00 | 0.00 |
| 8 | Retail | 0.00 | 0.00 |
| 9 | Group And Corporate | 0.00 | 0.00 |
| 10 | Any other class as may be specified by the Authority. - Enter the name below | ||
| Name of Other Segment | |||
| 1 | 0 | 0.00 | 0.00 |
| 2 | 0 | 0.00 | 0.00 |
| 3 | 0 | 0.00 | 0.00 |
| 4 | 0 | 0.00 | 0.00 |
| 5 | 0 | 0.00 | 0.00 |
| 6 | 0 | 0.00 | 0.00 |
| 7 | 0 | 0.00 | 0.00 |
| 8 | 0 | 0.00 | 0.00 |
| 9 | 0 | 0.00 | 0.00 |
| 10 | 0 | 0.00 | 0.00 |
| 11 | Unallocated | 0.00 | 0.00 |
Notes to the Operating ProfitLoss |
| 1. Health including Personal accident includes Travel Insurance. |
| Partiuclars | Current Quarter | ||
| Date of start of reporting period | 01-07-2025 | ||
| Date of end of reporting period | 30-09-2025 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Segment Technical Liabilities (Unexpired Risk Reserve-Net) | |||
| 1 | Fire | 0.00 | |
| 2 | Marine | 0.00 | |
| 3 | Health including personal accident | 2,78,219.00 | |
| 4 | Health Retail | 0.00 | |
| 5 | Health Group | 0.00 | |
| 6 | Health Government Schemes | 0.00 | |
| 7 | Motor | 0.00 | |
| 8 | Retail | 0.00 | |
| 9 | Group And Corporate | 0.00 | |
| 10 | Any other class as may be specified by the Authority. - Enter the name below | ||
| Name of Other Segment | |||
| 1 | 0 | 0.00 | |
| 2 | 0 | 0.00 | |
| 3 | 0 | 0.00 | |
| 4 | 0 | 0.00 | |
| 5 | 0 | 0.00 | |
| 6 | 0 | 0.00 | |
| 7 | 0 | 0.00 | |
| 8 | 0 | 0.00 | |
| 9 | 0 | 0.00 | |
| 10 | 0 | 0.00 | |
| 11 | Unallocated | 0.00 | |
Notes to the Technical Liabilities |
| 1. Health including Personal accident includes Travel Insurance. |
| Partiuclars | Current Quarter | ||
| Date of start of reporting period | 01-07-2025 | ||
| Date of end of reporting period | 30-09-2025 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Segment Technical Liabilities (Unexpired Claims Reserves Including IBNR & IIBNER) | |||
| 1 | Fire | 0.00 | |
| 2 | Marine | 0.00 | |
| 3 | Health including personal accident | 67,964.00 | |
| 4 | Health Retail | 0.00 | |
| 5 | Health Group | 0.00 | |
| 6 | Health Government Schemes | 0.00 | |
| 7 | Motor | 0.00 | |
| 8 | Retail | 0.00 | |
| 9 | Group And Corporate | 0.00 | |
| 10 | Any other class as may be specified by the Authority. - Enter the name below | ||
| Name of Other Segment | |||
| 1 | 0 | 0.00 | |
| 2 | 0 | 0.00 | |
| 3 | 0 | 0.00 | |
| 4 | 0 | 0.00 | |
| 5 | 0 | 0.00 | |
| 6 | 0 | 0.00 | |
| 7 | 0 | 0.00 | |
| 8 | 0 | 0.00 | |
| 9 | 0 | 0.00 | |
| 10 | 0 | 0.00 | |
| 11 | Unallocated | 0.00 | |
Notes to the Technical Liabilities |
| 1. Health including Personal accident includes Travel Insurance. |
| Partiuclars | Year ended (dd-mm-yyyy) | ||
| Date of start of reporting period | 01-04-2025 | ||
| Date of end of reporting period | 30-09-2025 | ||
| Whether results are audited or unaudited | Unaudited | ||
| Nature of report standalone or consolidated | Standalone | ||
| Sources of Funds | |||
| 1 | Share capital | 1,84,600.00 | |
| 2 | Reserves and surplus | 1,95,512.00 | |
| 3 | Share application money pending allotment | 0.00 | |
| 4 | Fair value change account | ||
| (a) | Policyholders funds | 300.00 | |
| (b) | Shareholders funds | 383.00 | |
| 5 | Borrowings | 25,000.00 | |
| 6 | Minority Interest | 0.00 | |
| Total Sources of Funds | 4,05,795.00 | ||
| APPLICATION OF FUNDS | |||
| 1 | Investments shareholders | 3,37,601.00 | |
| 2 | Investments policyholders | 5,10,575.00 | |
| 2 | Loans | 0.00 | |
| 3 | Fixed assets | 8,074.00 | |
| 4 | Deferred Tax Asset | 0.00 | |
| 5 | Current assets | ||
| Cash and bank balances | 8,830.00 | ||
| Advances and other assets | 1,15,446.00 | ||
| 6 | Sub-total (a) | 1,24,276.00 | |
| 7 | Current liabilities | 3,79,067.00 | |
| 8 | Provisions | 2,80,180.00 | |
| 9 | Sub-total (b) | 6,59,247.00 | |
| 10 | Net current assets (c) = (a - b) | (5,34,971.00) | |
| 11 | Miscellaneous expenditure (to the extent not written off or adjusted) | 0.00 | |
| 12 | Debit balance in profit & loss account (shareholder ' s account) | 84,516.00 | |
| 13 | Total | 4,05,795.00 | |
| 14 | Contigent Liabilities | 20,335.00 | |
| Particulars | Year ended (dd-mm-yyyy) | |
| A | Date of start of reporting period | 01-04-2025 |
| B | Date of end of reporting period | 30-09-2025 |
| C | Whether results are audited or unaudited | Unaudited |
| D | Nature of report standalone or consolidated | Standalone |
| Statement of cash flows | ||
| Cash flows from used in operating activities | ||
| Classes of cash receipts from operating activities | ||
| Receipts from sales of goods and rendering of services | 0.00 | |
| Receipts from royalties fees, commissions and other revenue | 0.00 | |
| Receipts from contracts held for dealing or trading purpose | 0.00 | |
| Receipts from premiums and claims annuities and other policy benefits | 4,39,133.00 | |
| Receipts from rents and subsequent sales of assets held for rental to others and subsequently held for sale | 0.00 | |
| Other cash receipts from operating activities | 0.00 | |
| Classes of cash payments from operating activities | ||
| Payments to suppliers for goods and services | 0.00 | |
| Payments from contracts held for dealing or trading purpose | 0.00 | |
| > | Payments to and on behalf of employees | 0.00 |
| Payments for premiums and claims, annuities and other policy benefits | 3,55,908.00 | |
| Payments to manufacture or acquire assets held for rental to others and subsequently held for sale | 0.00 | |
| Other cash payments from operating activities | 94,970.00 | |
| Net cash flows from (used in) operations | (11,745.00) | |
| Dividends received | 0.00 | |
| Interest paid | 0.00 | |
| Interest received | 0.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | (510.00) | |
| Net cash flows from (used in) operating activities | (12,255.00) | |
| Cash flows from used in investing activities | ||
| Cash flows from losing control of subsidiaries or other businesses | 0.00 | |
| Cash flows used in obtaining control of subsidiaries or other businesses | 0.00 | |
| Other cash receipts from sales of equity or debt instruments of other entities | 2,05,159.00 | |
| Other cash payments to acquire equity or debt instruments of other entities | 2,32,881.00 | |
| Other cash receipts from sales of interests in joint ventures | 0.00 | |
| Other cash payments to acquire interests in joint ventures | 0.00 | |
| Proceeds from sales of property, plant and equipment | 13.00 | |
| Purchase of property, plant and equipment | 2,066.00 | |
| Proceeds from sales of investment property | 0.00 | |
| Purchase of investment property | 0.00 | |
| Proceeds from sales of goodwill | 0.00 | |
| Purchase of goodwill | 0.00 | |
| Proceeds from sales of intangible assets | 0.00 | |
| Purchase of intangible assets | 0.00 | |
| Proceeds from biological assets other than bearer plants | 0.00 | |
| Purchase of biological assets other than bearer plants | 0.00 | |
| Proceeds from sales of other long-term assets | 0.00 | |
| Purchase of other long-term assets | 0.00 | |
| Cash advances and loans made to other parties | 0.00 | |
| Cash receipts from repayment of advances and loans made to other parties | 0.00 | |
| Cash payments for future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Cash receipts from future contracts, forward contracts, option contracts and swap contracts | 0.00 | |
| Dividends received | 0.00 | |
| Interest received | 26,892.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | (7.00) | |
| Proceeds from government grants | 0.00 | |
| Net cash flows from (used in) investing activities | (2,890.00) | |
| Cash flows from used in financing activities | ||
| Proceeds from changes in ownership interests in subsidiaries that do not result in loss of control | 0.00 | |
| Payments from changes in ownership interests in subsidiaries that do not result in loss of control | 0.00 | |
| Proceeds from issuing shares | 1,941.00 | |
| Proceeds from issuing other equity instruments | 0.00 | |
| Payments to acquire or redeem entity's shares | 0.00 | |
| Payments of other equity instruments | 0.00 | |
| Proceeds from exercise of stock options | 0.00 | |
| Proceeds from issuing debentures notes bonds etc | 0.00 | |
| Proceeds from borrowings | 0.00 | |
| Repayments of borrowings | 0.00 | |
| Payments of lease liabilities | 0.00 | |
| Dividends paid | 0.00 | |
| Interest paid | 0.00 | |
| Income taxes paid (refund) | 0.00 | |
| Other inflows (outflows) of cash | (1.00) | |
| Net cash flows from (used in) financing activities | 1,940.00 | |
| Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes | (13,205.00) | |
| Effect of exchange rate changes on cash and cash equivalents | ||
| Effect of exchange rate changes on cash and cash equivalents | 0.00 | |
| Net increase (decrease) in cash and cash equivalents | (13,205.00) | |
| Cash and cash equivalents cash flow statement at beginning of period | 22,035.00 | |
| Cash and cash equivalents cash flow statement at end of period | 8,830.00 | |
| Whether results are audited or unaudited | |
|---|---|
| Declaration of unmodified opinion or statement on impact of audit qualification | Not applicable |
| Auditor's opinion | |
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results |
| Sr No. | Audit firm's name | Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI | Certificate valid upto | ||
| Name of CEO / Managing director | |
|---|---|
| Name of CFO | |
| Name of audit committee chairman | |
| Name of statutory auditor | |
| Name of other signatory, if any, with designation | |
| Place | |
| Date |
| Mode of Fund Raising | Public Issues |
|---|---|
| Description of mode of fund raising (Applicable in case of others is selected) | |
| Date of Raising Funds | 12-11-2024 |
| Amount Raised | 80,000.00 |
| Report filed for Quarter ended | 30-09-2025 |
| Monitoring Agency | Not Applicable |
| Monitoring Agency Name, if applicable | |
| Is there a Deviation / Variation in use of funds raised | No |
| If yes, whether the same is pursuant to change in terms of a contract or objects, which was approved by the shareholders | |
| If Yes, Date of shareholder Approval | |
| Explanation for the Deviation / Variation | |
| Comments of the Audit Committee after review | |
| Comments of the auditors, if any |
| Sr. | Original Object | Modified Object, if any | Original Allocation | Modified allocation, if any | Funds Utilised | Amount of Deviation/Variation for the quarter according to applicable object | Remarks if any |
| 1 | Augmentation of capital base to maintain and strengthen solvency levels | Not Applicable | 80,000.00 | 0.00 | 80,000.00 | 0.00 | The Company raised funds through Public issue ('IPO') on November 12, 2024. During the quarter ended September 30, 2025, there was no fund raising in any manner. Further, please note that the Company has fully utilized the funds raised through IPO. |
| Name of signatory | VISHWANATH MAHENDRA |
| Designation of person | Chief Financial Officer |
| Place | Gurugram |
| Date | 03-11-2025 |
| Sr No. | Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. | ||||||||||||||||||||||||
| Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of the related party transaction ratified by the audit committee | Date of Audit Committee Meeting where the ratification was approved | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | Notes | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment ) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) | ||||||||||
| Total value of transaction during the reporting period | |||||||||||||||||||||||||